|
Balance Sheet Cash Flow Statement 2091 Stierlin Court Mountain View, CA 94043 CA Tel. 650-944-7000 Fax 650-944-7999 |
Type: Public
On the web:
http://www.alexza.com
Employees:
111
Employee growth: (22.9%)
Alexza Pharmaceuticals has found that some good can come out of smoking cigarettes. Though they deliver harmful chemicals, cigarettes deliver those chemicals almost instantly. That is the basis for Alexza Pharmaceutical's primary product, Staccato inhalers. The inhalers contain a heating element coated with a thin layer of medicine. Before use, the patient triggers the heating element, which vaporizes the medicine, allowing the patient to inhale it. The medicine is then rapidly absorbed through the lungs at a rate typically faster than oral and intravenous mediations. The company has been targeting neurological treatments including acute pain and anxiety therapies.
Key numbers for fiscal year ending December, 2008:
Sales: $0.5M
Net income: ($58.5)M
Officers:
President, CEO, and Director: Thomas B. King
SVP, CFO, and Secretary: August J. Moretti
Director Business Development: Tatjana Naranda
Competitors:
A.P. Pharma
Aradigm
Javelin Pharmaceuticals
